Joel Isaacson & Co’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,500
Closed -$12K 564
2016
Q4
$12K Hold
2,500
﹤0.01% 484
2016
Q3
$17K Buy
2,500
+1,000
+67% +$6.8K ﹤0.01% 488
2016
Q2
$8K Buy
+1,500
New +$8K ﹤0.01% 565